Supplementary Figure 3: Additional cell-tracking analyses.

a-c, Frequency of cells tracked from skull and tibia marrow in (a) stroke, 6hrs, n = 11, 5 experiments; 1 day, n = 13 for brain and spleen and n = 12 for blood, 5 experiments; 2 days, n = 7, 2 experiments; skull ***P = 0.001 and **P = 0.002 at 6hrs, *P = 0.022, *P = 0.03 at day 1; *P = 0.03, ns P = 0.22 at 2 days; tibia ns P = 0.46 at 6hrs, ns P = 0.69 at day 1, (b) carrageenan, n = 6, 4 experiments, Kruskall Wallis test, skull P = 0.51, tibia ns P = 0.65, (c) myocardial infarction, n = 5, 1 experiment, Kruskall Wallis test skull ns P = 0.11, tibia ns P = 0.32. d-f, Frequency of tracked cells in respective organs relative to the circulation after (d) stroke, at 6 hrs, n = 11, 5 experiments, ***P = 0.002, 1 day, n = 12, 5 experiments, P = 0.064 and 2 days, n = 5, 2 experiments, ns P = 0.13, (e) carrageenan injection, n = 6, 4 experiments and (f) after myocardial infarction, n = 5, 1 experiment. Data are mean ± s.e.m., ns indicates not significant, two-tailed Wilcoxon test unless otherwise specified.